Eye Zone Concentrate - Multi-intensive lifts, repairs, disinfects

Description

AQUA, GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, CETEARYL ALCOHOL, BETAINE (Sugar), HYDROGENATED COCO-GLYCERIDES, PENTYLENE GLYCOL, PANTHENOL (Pro-vitamin B5), GLYCERYL STEARATE, PEG-100 STEARATE (Nonionic surfactant), Theobroma grandiflorum seed butter (Cupuaçu), CETEARYL GLUCOSIDE (Nonionic surfactant), Altace Bark Extract (Silk tree), ACACIA FARNESIANA FLOWER WAX, CAFFEINE (Active ingredient derived from the Arabian coffee tree), STEARETH-21, DIMETHICONE (Silicone), PHENOXYETHANOL, CARBOMER, ETHYLHEXYLGLYCERIN, TOCOPHERYL ACETATE (Vitamin E derivative), MICA (Pearlescent colorant), POLYMETHYL METHACRYLATE, DISODIUM EDTA, ESCIN (Active ingredient derived from horse chestnut), PERFUM (Perfume), CI 77891 (White colorant: Titanium dioxide), BUTYLENE GLYCOL, DIMETHICONOL (Silicone), SODIUM HYDROXIDE, ALCOHOL (Drying alcohol), HARUNGANA MADAGASCARIENSIS EXTRACT (Haronga), OLEA EUROPAEA FRUIT EXTRACT (Olive), Paullinia cupana seed extract (Guarana), SODIUM BENZOATE, Acetyl Tetrapeptide-2 (Peptide), DEXTRAN This eye contour concentrate combines several active ingredients to target the main problems of the periorbital area. Caffeine** and escin** (a saponin extracted from horse chestnut) work in synergy to promote microcirculation and reduce venous stasis, helping to reduce puffiness and dark circles. Paullinia cupana** (guarana) extract, rich in methylxanthines, reinforces this draining effect. Acetyl Tetrapeptide-2** is a synthetic peptide that stimulates the production of extracellular matrix components, supporting skin firmness and the lifting effect. The **extract of Albizia julibrissin** (silk tree) is documented for its action on the contraction of dermal tension fibers. Dextran**, a high-molecular-weight polysaccharide, exerts an immediate mechanical tensor effect. Panthenol** and Theobroma grandiflorum butter** moisturize and strengthen the skin barrier. The formula is suitable for skin showing visible signs of fatigue, sagging or morning oedema in the eye area, from around the age of 30.